Safety of catheter ablation for atrial fibrillation in patients with cancer: a nationwide cohort study

References

• Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998;98(10):946–952.
   PubMed Web of Science ®Google Scholar
• Conen D, Wong JA, Sandhu RK, et al. Risk of malignant cancer among women with new-onset atrial fibrillation. JAMA Cardiol. 2016;1(4):389–396.
   PubMed Web of Science ®Google Scholar
• O’Neal WT, Lakoski SG, Qureshi W, et al. Relation between cancer and atrial fibrillation (from the reasons for geographic and racial differences in stroke study). Am J Cardiol. 2015;115(8):1090–1094.
   PubMed Web of Science ®Google Scholar
• Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) [published correction appears in Eur Heart J. 2016 Dec 24]. Eur Heart J. 2016;37(36):2768–2801.
   PubMed Web of Science ®Google Scholar
• Onaitis M, D’Amico T, Zhao Y, et al. Risk factors for atrial fibrillation after lung cancer surgery: analysis of the society of thoracic surgeons general thoracic surgery database. Ann Thorac Surg. 2010;90(2):368–374.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Thurlapati A, Thotamgari S, et al. Anti-cancer drugs associated atrial fibrillation—an analysis of real-world pharmacovigilance data. Front Cardiovasc Med. 2022 [Accessed Apr 15, 2022];9. https://www.frontiersin.org/article/10.3389/fcvm.2022.739044.
   Web of Science ®Google Scholar
• Apte N, Dherange P, Mustafa U, et al. Cancer radiation therapy may be associated with atrial fibrillation. Front Cardiovasc Med. 2021 Published 2021 Jan 22;8:610915. DOI:10.3389/fcvm.2021.610915
   PubMed Web of Science ®Google Scholar
• Jakobsen CB, Lamberts M, Carlson N, et al. Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study. BMC Cancer. 2019;19(1):1105.
   PubMed Web of Science ®Google Scholar
• Han H, Chen L, Lin Z, et al. Prevalence, trends, and outcomes of atrial fibrillation in hospitalized patients with metastatic cancer: findings from a national sample [published correction appears in Cancer Med. 2021 Oct;10(20): 7441]. Cancer Med. 2021;10(16):5661–5670.
   PubMed Web of Science ®Google Scholar
• Yun JP, Choi EK, Han KD, et al. Risk of Atrial Fibrillation According to Cancer Type: a Nationwide Population-Based Study. JACC CardioOncol. 2021;3(2):221–232.
   PubMedGoogle Scholar
• Fauchier L, Villejoubert O, Clementy N, et al. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. Am j med. 2016;129(12):1278–1287.
   PubMed Web of Science ®Google Scholar
• Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825–1833.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305–1316.
   PubMed Web of Science ®Google Scholar
• Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–666.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Overview of the national inpatient sample (NIS). Rockville: AHRQ. Accessed Feb 19, 2021. https://www.hcup-us.ahrq.gov/nisoverview.jsp
   Google Scholar
• Deshmukh A, Patel NJ, Pant S, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 128(19): Epub 2013 Sep 23. PMID: 24061087:2104–2112. 2013 Nov 5. DOI:10.1161/CIRCULATIONAHA.113.003862
   PubMed Web of Science ®Google Scholar
• Johns Hopkins ACG® system. Johns Hopkins ACG® System. https://www.hopkinsacg.org/. Published Feb 3, 2023. Accessed Apr 28, 2023
   Google Scholar
• Kattelus H, Kesäniemi YA, Huikuri H, et al. Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study).PLoS ONE. 2018 [Published 2018 Oct 5];13(10):e0205454. DOI:10.1371/journal.pone.0205454
   PubMed Web of Science ®Google Scholar
• Hu YF, Liu CJ, Chang PM, et al. Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients. Int J Cardiol. 2013;165(2):355–357.
   PubMed Web of Science ®Google Scholar
• Saglietto A, Gaita F, De Ponti R, et al. Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: a Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Cardiovasc Med. 2021 Published 2021 May 21;8:664647. DOI:10.3389/fcvm.2021.664647
   PubMed Web of Science ®Google Scholar
• Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients with Atrial Fibrillation: the CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–1274. DOI:10.1001/jama.2019.0693
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018;378(5):417–427.
   PubMed Web of Science ®Google Scholar
• López-Fernández T, Martín-García A, Roldán Rabadán I, et al. Atrial Fibrillation in Active Cancer Patients: expert Position Paper and Recommendations. Rev Esp Cardiol (Engl Ed). 2019;72(9):749–759.
   PubMed Web of Science ®Google Scholar
• Hajjar LA, Fonseca SMR, Machado TIV. Atrial Fibrillation and Cancer. Front Cardiovasc Med. 2021 Published 2021 Jul 15;8:590768. DOI:10.3389/fcvm.2021.590768
   PubMed Web of Science ®Google Scholar
• Farmakis D, Parissis J, Filippatos G. Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol. 2014;63(10):945–953.
   PubMed Web of Science ®Google Scholar
• Eitel C, Sciacca V, Bartels N, et al. Safety and Efficacy of Cryoballoon Based Pulmonary Vein Isolation in Patients with Atrial Fibrillation and a History of Cancer. J Clin Med. 2021;10(16):3669.
   PubMed Web of Science ®Google Scholar
• Giustozzi M, Ali H, Reboldi G, et al. Safety of catheter ablation of atrial fibrillation in cancer survivors. J Interv Card Electrophysiol. 2021;60(3):419–426.
   PubMed Web of Science ®Google Scholar
• Angelini DE, Radivoyevitch T, McCrae KR, et al. Bleeding incidence and risk factors among cancer patients treated with anticoagulation. Am J Hematol. 2019;94(7):780–785.
   PubMed Web of Science ®Google Scholar
• Chen ST, Hellkamp AS, Becker RC, et al. Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF. Eur Heart J Qual Care Clin Outcomes. 2019;5(2):145–152.
   PubMed Web of Science ®Google Scholar
• Fanola CL, Ruff CT, Murphy SA, et al. Efficacy and Safety of Edoxaban in Patients with Active Malignancy and Atrial Fibrillation: analysis of the ENGAGE AF - TIMI 48 Trial. J Am Heart Assoc. 2018;7(16):e008987.
   PubMed Web of Science ®Google Scholar
• Sato T, Aizawa Y, Fuse K, et al. The Impact of Cancer on Major Bleeding and Stroke/Systemic Emboli in Patients Using Direct Oral Anticoagulants: from the Database of a Single-Center Registry. J Atr Fibrillation. 2018;11(4):2105.
   PubMedGoogle Scholar
• Nakatsuma K, Shiomi H, Morimoto T, et al. Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2). Eur Heart J Qual Care Clin Outcomes. 2018;4(3):200–207.
   PubMed Web of Science ®Google Scholar
• Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–1582.
   PubMed Web of Science ®Google Scholar
• Rozen G, Elbaz-Greener G, Andria N, et al. Safety of catheter ablation for atrial fibrillation in patients with mechanical prosthetic valves. J Cardiovasc Electrophysiol. 2022;33(6):1128–1135.
   PubMed Web of Science ®Google Scholar
• Hess CN, Roe MT, Clare RM, et al. Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention. J Am Heart Assoc. 2015;4(7):e001779.
   PubMed Web of Science ®Google Scholar
• Velders MA, Boden H, Hofma SH, et al. Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol. 2013;112(12):1867–1872.
   PubMed Web of Science ®Google Scholar
• Landes U, Kornowski R, Bental T, et al. Long-term outcomes after percutaneous coronary interventions in cancer survivors. Coron Artery Dis. 2017;28(1):5–10.
   PubMed Web of Science ®Google Scholar
• Wang F, Gulati R, Lennon RJ, et al. Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Mayo Clin Proc. 2016;91(12):1680–1692.
   PubMed Web of Science ®Google Scholar
• Khakoo AY, Yeh ET. Therapy insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol. 2008;5(11):655–667.
   PubMedGoogle Scholar
• Caine GJ, Stonelake PS, Lip GY, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465–473.
   PubMed Web of Science ®Google Scholar